Marubi(SH:603983) 3 6 Ke·2025-11-12 11:03Group 1: Company Developments - Marubi Biotechnology plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance capital strength and international competitiveness [1] - Zhejiang Shimai Pharmaceutical Co., Ltd. has submitted an IPO application to the Hong Kong Stock Exchange, with Huatai International as the exclusive sponsor [3] - BeiGene reported third-quarter revenue of 10.077 billion yuan, a year-on-year increase of 41.1%, and a net profit of 689 million yuan, marking a turnaround from loss [4] - Tencent Music announced third-quarter total revenue of 8.46 billion yuan, a year-on-year increase of 20.6%, with adjusted net profit rising by 27.7% [5] Group 2: Market Trends - Bilibili reported a 109% year-on-year increase in the number of clients advertising during the Double 11 shopping festival, with GMV for products priced over 1,000 yuan increasing by 63% [2] - The average new customer rate across all industries on Bilibili reached 55%, with certain sectors like watches and beauty exceeding 60% [2] Group 3: Industry Insights - The Bank of Korea's governor indicated that future interest rate changes will depend on upcoming data, maintaining a stance of monetary easing [6][7] - The National Energy Administration of China is exploring the construction of energy storage systems to enhance the integration of renewable energy [7] - The first electric vertical take-off and landing flying car factory in Guangzhou has entered trial production, marking a significant step towards large-scale manufacturing in the low-altitude economy [8]